Back

Incidence and Predictors of Arterial Thrombosis in Cancer Patients: The Prospective COMPASS-Arterial Cancer Associated Thrombosis (COMPASS-ARTeCAT) Study

30 August 2026 (11:30 - 11:45)
Organised by: Logo
Congress Presentation Part of: Late-Breaking Clinical Science: cardio-oncology Cardio-Oncology ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Maria Drakopoulou

University of Athens, Athens (Greece)

3 More presentations in this session

Presentation thumbnail
A RAndomizeD Intervention for CArdiovascular and Lifestyle Risk Factors in Prostate Cancer Patients
Doctor D. Leong (Hamilton, CA)
Slides Video
Presentation thumbnail
An open-label, randomised controlled trial to investigate the safety of withdrawal of pharmacological treatment for recovered HER2 targeted therapy related cardiac dysfunction.
Doctor B. Dowsing (London, GB)
Slides Video
Presentation thumbnail
Heart Failure and Incident Hematologic Malignancies: A Nationwide Population-Based Cohort Study
Doctor S. Lee (Seoul, KR)
Slides Video

Access the full session

Session thumbnail
Late-Breaking Clinical Science: cardio-oncology
Video

The Event

Event poster

ESC Congress 2026

30 August 2026 11:30 CET
You may be interested in
thumbnail
Webinar
Cancer associated thrombosis: have DOACs changed daily practice?
21 September 2021
thumbnail
Congress Presentation
Immune checkpoint inhibitors and atherosclerotic cardiovascular events: a retrospective cohort study
27 August 2023
thumbnail
Congress Presentation
Risk factors of recurrence in patients with cancer-associated venous thromboembolism: from the COMMAND VTE Registry
28 August 2021
thumbnail
Webinar
Cardiac emergencies in cardio-oncology
12 April 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources